Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2020

Jan 6, 2020

29745_dirs_2020-01-06_a25e5720-a3d3-418c-9188-50fd0f97e8f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-01-02

Reporting Person: Harrington Michael J (Senior VP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-24 Common Stock G 3000 Disposed 59500 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-02 Restricted Stock Unit $ A 1608 Acquired 2021-01-02 Common Stock (1608.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 452 Indirect
Common Stock 47800 Direct

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.